Correlation Between Verve Therapeutics and 10X Genomics

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and 10X Genomics, you can compare the effects of market volatilities on Verve Therapeutics and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and 10X Genomics.

Diversification Opportunities for Verve Therapeutics and 10X Genomics

-0.11

Correlation Coefficient

Verve Therapeutics  10X Genomics

Good diversification

The 3 months correlation between Verve and 10X is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and 10X Genomics go up and down completely randomly.

Pair Corralation between Verve Therapeutics and 10X Genomics

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 1.3 times more return on investment than 10X Genomics. However, Verve Therapeutics is 1.3 times more volatile than 10X Genomics. It trades about -0.01 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.08 per unit of risk. If you would invest  1,241  in Verve Therapeutics on September 4, 2024 and sell it today you would lose (525.00) from holding Verve Therapeutics or give up 42.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  10X Genomics

Verve Therapeutics

Risk-Adjusted Performance

5 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Verve Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Verve Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

10X Genomics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Verve Therapeutics and 10X Genomics

The main advantage of trading using opposite Verve Therapeutics and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.

The idea behind Verve Therapeutics and 10X Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..